Navigation Links
Gleevec gets hopeful results

The Food and Drug Administration approved the drug, Gleevec, for the treatment of chronic myelogenous leukemia, a form of cancer that affects about 4,500 people in the USA each year. A study supports Gleevec's image as a potential cure for this kind of cancer, which, although cases are rare, can be deadly. //

A new study adds to the evidence suggesting that a heavily publicized drug treatment for a type of leukemia may allow patients to live longer than expected. Experts say the drug, made by Novartis Pharmaceuticals also holds promise for the treatment of lung cancer, prostate cancer and a form of stomach cancer.

In the longest study of the drug so far, researchers studied 532 patients with chronic leukemia. They all had received the standard drug, interferon, but after six months their cancer had gotten worse. The patients were switched to Gleevec, which they took once a day. After 18 months, the researchers could find no visible sign of the genetic abnormality that causes the disease in 41% of the patients.

That genetic flaw leads to the production of a protein that allows white cells in the blood and in the bone marrow to run out of control. Gleevec works by blocking the action of that protein.
'"/>




Page: 1

Related medicine news :

1. Gleevec for Lung Disease
2. "Miracle" Cancer Drug Gleevec Can be Toxic to the Heart
3. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
4. Artificial disc looks hopeful
5. Experimental treatment for Ebola Virus Shows promising results in mice
6. IVF results may be affected by stress and other related factors
7. New dosage of medicine gets more results in neuroblastoma
8. Caffeine can interfere with PET scan results
9. Mouth wash samples to predict bone marrow transplant results
10. PET scans can detect the results of cognitive behavior therapy
11. Induced abortion results in years of trauma.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... ... July 26, 2017 , ... ... Engineering (ISPE) will host its 2017 Process Validation and Process Validation ... offer comprehensive solutions to process validation lifecycle challenges faced by process validation ...
(Date:7/26/2017)... ... 2017 , ... A global center of excellence specializing in ... of the art center will provide advanced surgical care (heart surgery), management of ... patients longer lives. , North American Veterinary Heart Center, the “Heart Center,” will ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... innovative specialty pharmacies, has released an updated version of the HCV Treatment Path ... for treating chronic hepatitis C virus (HCV) infection. All of the latest HCV ...
(Date:7/25/2017)... ... 25, 2017 , ... Creative Pharmacist and ... the Pharmacist eCare Plan to Computer-Rx pharmacies through the STRAND platform. ... to develop the Pharmacist eCare Plan, a shared document detailing a patient’s current ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Gina Negrette, a ... more than a decade of experience in psychiatry, treating clients in diverse settings, ... eating disorders, psychotic and manic conditions, as well as those who were fighting ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... The Institute for In Vitro Sciences (IIVS), ... of a VITROCELL® inhalation exposure system thanks to a ... device, which is designed to replace animals in inhalation ... to airborne test materials in an environment that mimics ... for testing combustible tobacco products, as well as next ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/6/2017)... , July 6, 2017 ThriveRx, the nutrition division of Diplomat ... families to thrive on nutrition support. To celebrate its anniversary, ... site has a fresh new look with improved organization to create the ... ... "We,ve ...
Breaking Medicine Technology: